Colgate-Palmolive (NYSE:CL) Shares Bought by HB Wealth Management LLC

HB Wealth Management LLC lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 71,771 shares of the company’s stock after purchasing an additional 798 shares during the period. HB Wealth Management LLC’s holdings in Colgate-Palmolive were worth $6,525,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of CL. D Orazio & Associates Inc. increased its stake in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after purchasing an additional 108 shares during the last quarter. Fiducient Advisors LLC grew its position in shares of Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after buying an additional 110 shares during the last quarter. Sequoia Financial Advisors LLC raised its stake in Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after acquiring an additional 113 shares during the period. Great Waters Wealth Management lifted its holdings in Colgate-Palmolive by 1.5% in the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock worth $796,000 after acquiring an additional 117 shares during the last quarter. Finally, Waldron Private Wealth LLC boosted its stake in Colgate-Palmolive by 2.1% in the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after acquiring an additional 118 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CL has been the topic of a number of research reports. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday. TD Cowen cut their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Price Performance

NYSE CL opened at $88.79 on Friday. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30. The business’s fifty day moving average is $92.20 and its two-hundred day moving average is $97.74. The stock has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 57.31%.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.37% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.